LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 110 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,420,669 | -8.7% | 1,203,957 | +9.1% | 0.00% | – |
Q2 2023 | $1,555,416 | +337.4% | 1,103,132 | +365.3% | 0.00% | – |
Q1 2023 | $355,625 | +36.0% | 237,083 | +6.1% | 0.00% | – |
Q4 2022 | $261,437 | +3.7% | 223,450 | 0.0% | 0.00% | – |
Q3 2022 | $252,000 | -21.0% | 223,450 | +10.7% | 0.00% | – |
Q2 2022 | $319,000 | -79.9% | 201,775 | -80.4% | 0.00% | – |
Q1 2022 | $1,587,000 | -40.1% | 1,030,809 | -4.6% | 0.00% | – |
Q4 2021 | $2,648,000 | -29.8% | 1,080,924 | -27.8% | 0.00% | -100.0% |
Q3 2021 | $3,774,000 | -18.7% | 1,497,627 | -8.1% | 0.00% | 0.0% |
Q2 2021 | $4,641,000 | +566.8% | 1,628,749 | +449.7% | 0.00% | – |
Q1 2021 | $696,000 | +51.0% | 296,293 | +13.1% | 0.00% | – |
Q4 2020 | $461,000 | +82.9% | 262,029 | -2.6% | 0.00% | – |
Q3 2020 | $252,000 | +19.4% | 269,056 | +10.7% | 0.00% | – |
Q2 2020 | $211,000 | -80.1% | 243,135 | -81.0% | 0.00% | – |
Q1 2020 | $1,062,000 | +3.0% | 1,282,556 | +10.8% | 0.00% | – |
Q4 2019 | $1,031,000 | -12.4% | 1,157,701 | -3.6% | 0.00% | – |
Q3 2019 | $1,177,000 | – | 1,201,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $40,874,517 | 3.42% |
Defender Capital, LLC. | 5,093,535 | $5,959,436 | 2.41% |
Raffles Associates | 1,536,946 | $1,798,230 | 2.10% |
Prescott General Partners LLC | 1,851,851 | $2,166,666 | 0.18% |
DAFNA Capital Management LLC | 140,000 | $163,800 | 0.05% |
Fort Sheridan Advisors LLC | 83,931 | $98,199 | 0.03% |
Beirne Wealth Consulting Services, LLC | 45,000 | $52,650 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $914,666 | 0.02% |
ETF MANAGERS GROUP, LLC | 353,991 | $414,169 | 0.02% |
Straight Path Wealth Management | 16,200 | $18,954 | 0.02% |